08.01.2013
- Sartorius Stedim Biotech, a pharmaceutical and biotech supplier, today announced a substantial expansion of its product rray in the cell culture range. The company signed a...
31.10.2012
- Swiss drugs industry supplier Lonza plans to cut 500 jobs, including 400 at its main plant in Visp, to improve profitability as it grapples with price pressures, a strong Swiss...
23.10.2012
- Lonza and OncoMed Pharmaceuticals, a clinical-stage biopharmaceutical company dedicated to improving cancer treatment, announced today an agreement for the development and...
23.10.2012
- Cobra Biologics, the international clinical and commercial manufacturer of biologics and pharmaceuticals, announces the appointment of a new non-executive director to Cobra...
25.07.2012
- Swiss drug industry supplier Lonza confirmed its profit guidance on Wednesday and said demand in its key business remained strong despite macroeconomic uncertainties. The Basel...
25.06.2012
- FivePrime Therapeutics has entered into research and commercial agreements with Biowa and Lonza to use their Potelligent CHOK1SV Cell Line for the research, development and...
16.06.2012
- Lonza, a global leader in the field of biologics manufacturing, today announced the successful completion of its new GMP clean room within its Houston, Texas operations. The clean...
12.04.2012
- Lonza and Agennix announced an agreement for the production of Agennix's first-in-class oral Dendritic Cell Mediated Immunotherapy (DCMI), talactoferrin, currently in Phase III...
